207 related articles for article (PubMed ID: 36677652)
1. Synthesis, Biological Evaluation and Molecular Modeling Studies of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives as P2X7 Inhibitors.
Pacheco PAF; Gonzaga DTG; von Ranke NL; Rodrigues CR; da Rocha DR; da Silva FC; Ferreira VF; Faria RX
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677652
[TBL] [Abstract][Full Text] [Related]
2. 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
Pacheco PAF; Galvão RMS; Faria AFM; Von Ranke NL; Rangel MS; Ribeiro TM; Bello ML; Rodrigues CR; Ferreira VF; da Rocha DR; Faria RX
Bioorg Med Chem; 2019 Apr; 27(8):1449-1455. PubMed ID: 30528164
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation and molecular modeling studies of novel 1,2,3-triazole-linked menadione-furan derivatives as P2X7 inhibitors.
Dos Santos JPS; Ribeiro RCB; Faria JV; Bello ML; Lima CGS; Pauli FP; Borges AA; Rocha DR; Moraes MG; Forezi LSM; Ferreira VF; Faria RX; da Silva FC
J Bioenerg Biomembr; 2022 Dec; 54(5-6):227-239. PubMed ID: 36070071
[TBL] [Abstract][Full Text] [Related]
4. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
[TBL] [Abstract][Full Text] [Related]
5. 1,4-Naphthoquinones potently inhibiting P2X7 receptor activity.
Faria RX; Oliveira FH; Salles JP; Oliveira AS; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; Louvis AR; Martins DL; Ferreira VF
Eur J Med Chem; 2018 Jan; 143():1361-1372. PubMed ID: 29133043
[TBL] [Abstract][Full Text] [Related]
6. Synthetic 1,4-Naphthoquinones inhibit P2X7 receptors in murine neuroblastoma cells.
Pislyagin E; Kozlovskiy S; Menchinskaya E; Chingizova E; Likhatskaya G; Gorpenchenko T; Sabutski Y; Polonik S; Aminin D
Bioorg Med Chem; 2021 Feb; 31():115975. PubMed ID: 33401207
[TBL] [Abstract][Full Text] [Related]
7. Anti-Inflammatory Activity of 1,4-Naphthoquinones Blocking P2X7 Purinergic Receptors in RAW 264.7 Macrophage Cells.
Kozlovskiy SA; Pislyagin EA; Menchinskaya ES; Chingizova EA; Sabutski YE; Polonik SG; Likhatskaya GN; Aminin DL
Toxins (Basel); 2023 Jan; 15(1):. PubMed ID: 36668867
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
[TBL] [Abstract][Full Text] [Related]
9. In silico and pharmacological study of N,S-acetal juglone derivatives as inhibitors of the P2X7 receptor-promoted in vitro and in vivo inflammatory response.
Pacheco PAF; Faria JV; Silva AC; von Ranke NL; Silva RC; Rodrigues CR; da Rocha DR; Faria RX
Biomed Pharmacother; 2023 Jun; 162():114608. PubMed ID: 37003033
[TBL] [Abstract][Full Text] [Related]
10. Tetracyclic 1,4-Naphthoquinone Thioglucoside Conjugate U-556 Blocks the Purinergic P2X7 Receptor in Macrophages and Exhibits Anti-Inflammatory Activity In Vivo.
Kozlovskiy S; Pislyagin E; Menchinskaya E; Chingizova E; Kaluzhskiy L; Ivanov AS; Likhatskaya G; Agafonova I; Sabutski Y; Polonik S; Manzhulo I; Aminin D
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569745
[TBL] [Abstract][Full Text] [Related]
11. Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor.
Fresta CG; Caruso G; Fidilio A; Platania CBM; Musso N; Caraci F; Drago F; Bucolo C
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291318
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway.
Fan J; Zhao RQ; Parro C; Zhao W; Chou HY; Robert J; Deeb TZ; Raynoschek C; Barichievy S; Engkvist O; Maresca M; Hicks R; Meuller J; Moss SJ; Brandon NJ; Wood MW; Kulic I; Wellington CL
J Lipid Res; 2018 May; 59(5):830-842. PubMed ID: 29563219
[TBL] [Abstract][Full Text] [Related]
13. Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
Allsopp RC; Dayl S; Schmid R; Evans RJ
Sci Rep; 2017 Apr; 7(1):725. PubMed ID: 28389651
[TBL] [Abstract][Full Text] [Related]
14. Arylboronic acids inhibit P2X7 receptor function and the acute inflammatory response.
Faria RX; de Jesus Hiller N; Salles JP; Resende JALC; Diogo RT; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; de Luna Martins D
J Bioenerg Biomembr; 2019 Aug; 51(4):277-290. PubMed ID: 31256283
[TBL] [Abstract][Full Text] [Related]
15. Constructing an atomic-resolution model of human P2X7 receptor followed by pharmacophore modeling to identify potential inhibitors.
Ahmadi M; Nowroozi A; Shahlaei M
J Mol Graph Model; 2015 Sep; 61():243-61. PubMed ID: 26298810
[TBL] [Abstract][Full Text] [Related]
16. Mapping the Site of Action of Human P2X7 Receptor Antagonists AZ11645373, Brilliant Blue G, KN-62, Calmidazolium, and ZINC58368839 to the Intersubunit Allosteric Pocket.
Bin Dayel A; Evans RJ; Schmid R
Mol Pharmacol; 2019 Sep; 96(3):355-363. PubMed ID: 31263019
[TBL] [Abstract][Full Text] [Related]
17. Escape from adamantane: Scaffold optimization of novel P2X7 antagonists featuring complex polycycles.
Barniol-Xicota M; Kwak SH; Lee SD; Caseley E; Valverde E; Jiang LH; Kim YC; Vázquez S
Bioorg Med Chem Lett; 2017 Feb; 27(4):759-763. PubMed ID: 28126517
[TBL] [Abstract][Full Text] [Related]
18. Docking of competitive inhibitors to the P2X7 receptor family reveals key differences responsible for changes in response between rat and human.
Caseley EA; Muench SP; Baldwin SA; Simmons K; Fishwick CW; Jiang LH
Bioorg Med Chem Lett; 2015 Aug; 25(16):3164-7. PubMed ID: 26099538
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor.
Lee S; Ha H; Jang J; Byun Y
Curr Med Chem; 2023; 30(2):164-177. PubMed ID: 35770396
[TBL] [Abstract][Full Text] [Related]
20. Mapping the Allosteric Action of Antagonists A740003 and A438079 Reveals a Role for the Left Flipper in Ligand Sensitivity at P2X7 Receptors.
Allsopp RC; Dayl S; Bin Dayel A; Schmid R; Evans RJ
Mol Pharmacol; 2018 May; 93(5):553-562. PubMed ID: 29535152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
